Endo-alpha-sialidase (3.2.1.129)

Industry

CPC
C12Y302/01129

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y302/00Hydrolases acting on glycosyl compounds

Current Industry

C12Y302/01129Endo-alpha-sialidase (3.2.1.129)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-tumor medicament based on adenovirus
- Patent number 10,851,359
- Issue date Dec 1, 2020
- Medizinische Hochschule Hannover
- Rita Gerardy-Schahn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Composition comprising double stranded RNA that inhibits expression...
- Patent number 7,795,233
- Issue date Sep 14, 2010
- Miyagi Ken
- Taeko Miyagi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant protein having bacteriophage endosialidase enzymatic ac...
- Patent number 6,331,425
- Issue date Dec 18, 2001
- Endozyme Limited
- Peter William Taylor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
KDN-cleaving sialidase isolated from hepatopancreas of mollusks
- Patent number 5,449,615
- Issue date Sep 12, 1995
- Yuh-Teh Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enzyme complex hydrolyzing bacterial cell walls derived from nocard...
- Patent number 5,354,681
- Issue date Oct 11, 1994
- 501 Novo Industri A/S
- Chi-Li Liu
- C11 - ANIMAL AND VEGETABLE OILS, FATS, FATTY SUBSTANCES AND WAXES FATTY ACIDS...

Patents Applicationslast 30 patents

Information Patent Application
DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR M...
- Publication number 20220370527
- Publication date Nov 24, 2022
- Ansun Biopharma, Inc.
- Nancy Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED GENE THERAPY TARGETING RETINAL CELLS
- Publication number 20220226507
- Publication date Jul 21, 2022
- Research Institute at Nationwide Children's Hospital
- Kathrin Christine Meyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Destroying Cancer Cells While Maintaining Healthy Cell Integrity
- Publication number 20220168367
- Publication date Jun 2, 2022
- Richard Postrel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TUMOR MEDICAMENT BASED ON ADENOVIRUS
- Publication number 20180163190
- Publication date Jun 14, 2018
- Medizinische Hochschule Hannover
- Rita Gerardy-Schahn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for RNA interference with sialidase expres...
- Publication number 20090203055
- Publication date Aug 13, 2009
- Massachusetts Institute of Technology
- Frederyk Ngantung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER OR DIABETES
- Publication number 20090149402
- Publication date Jun 11, 2009
- Taeko Miyagi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Endo-alpha-sialidase (3.2.1.129)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Anti-tumor medicament based on adenovirus

Composition comprising double stranded RNA that inhibits expression...

Recombinant protein having bacteriophage endosialidase enzymatic ac...

KDN-cleaving sialidase isolated from hepatopancreas of mollusks

Enzyme complex hydrolyzing bacterial cell walls derived from nocard...

Patents Applicationslast 30 patents

DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR M...

OPTIMIZED GENE THERAPY TARGETING RETINAL CELLS

Destroying Cancer Cells While Maintaining Healthy Cell Integrity

ANTI-TUMOR MEDICAMENT BASED ON ADENOVIRUS

Compositions and methods for RNA interference with sialidase expres...

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER OR DIABETES